Acazicolcept

Modify Date: 2024-04-12 22:01:12

Acazicolcept Structure
Acazicolcept structure
Common Name Acazicolcept
CAS Number 2797026-97-0 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Acazicolcept


Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities[1].

 Names

Name Acazicolcept

 Acazicolcept Biological Activity

Description Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities[1].
Related Catalog
In Vivo Azacicolcept (267-400 μg/mouse; i.p.; twice a week; for 6 weeks) 可减少皮肤和肺纤维化并缓解肺动脉高压[1]。 Animal Model: Six-week-old female BALB/c mice induced by hypochlorous acid (HOCL)[1] Dosage: 267 μg/mouse and 400 μg/mouse Administration: i.p.; twice a week; for 6 weeks Result: Induced a significant decrease in dermal thickness, collagen content, myofibroblast number, and inflammatory infiltrates characterized by B cells, T cells, neutrophils, and macrophages.
References

[1]. Cindy Orvain, et al. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models. Arthritis Res Ther. 2022 Jan 5;24(1):13.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.